QDEL
Quidelortho Corp

3,554
Mkt Cap
$1.54B
Volume
989,845.00
52W High
$41.40
52W Low
$19.50
PE Ratio
-1.36
QDEL Fundamentals
Price
$21.48
Prev Close
$22.60
Open
$21.72
50D MA
$28.30
Beta
1.32
Avg. Volume
1.36M
EPS (Annual)
-$16.69
P/B
0.80
Rev/Employee
$419,538.46
$4,650.64
Loading...
Loading...
News
all
press releases
Segall Bryant & Hamill LLC Sells 71,044 Shares of QuidelOrtho Corporation $QDEL
Segall Bryant & Hamill LLC reduced its position in shares of QuidelOrtho Corporation (NASDAQ:QDEL - Free Report) by 5.5% in the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·14h ago
News Placeholder
More News
News Placeholder
Vanguard Group Inc. Has $224.89 Million Stock Position in QuidelOrtho Corporation $QDEL
Vanguard Group Inc. reduced its holdings in QuidelOrtho Corporation (NASDAQ:QDEL - Free Report) by 2.1% during the 3rd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·2d ago
News Placeholder
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires
Key PointsA board director at QuidelOrtho Corp. acquired 10,000 common shares on Feb. 13, 2026, at an average price of around $23.96 per share, totaling ~$240,000...
Nasdaq News: Markets·2d ago
News Placeholder
QuidelOrtho Corporation (NASDAQ:QDEL) Receives Average Recommendation of "Reduce" from Brokerages
QuidelOrtho Corporation (NASDAQ:QDEL - Get Free Report) has received an average rating of "Reduce" from the six brokerages that are covering the stock, Marketbeat.com reports. Three investment...
MarketBeat·3d ago
News Placeholder
Faster Cardiac Answers with HighSensitivity Troponin
Faster Cardiac Answers with HighSensitivity Troponin Faster Cardiac Answers with HighSensitivity Troponin PR Newswire SAN DIEGO, Feb. 19, 2026 SAN DIEGO, Feb. 19, 2026 /PRNewswire/ -- QuidelOrtho...
PR Newswire·12d ago
News Placeholder
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference PR Newswire SAN...
PR Newswire·13d ago
News Placeholder
QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement
QuidelOrtho inks Lifotronic supply deal, adding 70+ assays and new analyzer platforms to boost global immunoassay reach and recurring revenue potential.
Zacks·14d ago
News Placeholder
Matthew Strobeck Buys 10,000 Shares of QuidelOrtho (NASDAQ:QDEL) Stock
QuidelOrtho Corporation (NASDAQ:QDEL - Get Free Report) Director Matthew Strobeck purchased 10,000 shares of the company's stock in a transaction that occurred on Friday, February 13th. The stock was...
MarketBeat·18d ago
News Placeholder
Insider Buying: QuidelOrtho (NASDAQ:QDEL) Director Acquires 10,000 Shares of Stock
QuidelOrtho Corporation (NASDAQ:QDEL - Get Free Report) Director Matthew Strobeck purchased 10,000 shares of QuidelOrtho stock in a transaction that occurred on Friday, February 13th. The shares were...
MarketBeat·18d ago
News Placeholder
QuidelOrtho (NASDAQ:QDEL) CEO Brian Blaser Acquires 10,540 Shares
QuidelOrtho Corporation (NASDAQ:QDEL - Get Free Report) CEO Brian Blaser acquired 10,540 shares of the business's stock in a transaction dated Friday, February 13th. The shares were purchased at an...
MarketBeat·18d ago
<
1
2
...
>

Latest QDEL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.